Cargando…
Virtual screening based on the structure of more than 10(5) compounds against four key proteins of SARS-CoV-2: M(Pro), S(RBD), RdRp, and PL(pro)
BACKGROUND: SARS-CoV-2 initially originated in Wuhan (China) around December 2019, and spread all over the world. Currently, WHO (Word Health Organization) has licensed several vaccines for this viral infection. However, not everyone can be vaccinated. People with underlying health conditions that w...
Autores principales: | Nabati, Farzan, kamyabiamineh, Ayshin, Kosari, Ramin, Ghasemi, Faezeh, Seyedebrahimi, Seyedehmasoumeh, Mohammadi, Sobhan, Moradi, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652154/ https://www.ncbi.nlm.nih.gov/pubmed/36406927 http://dx.doi.org/10.1016/j.imu.2022.101134 |
Ejemplares similares
-
In silico study of natural compounds from sesame against COVID-19 by targeting M(pro), PL(pro) and RdRp
por: Allam, Ahmed E., et al.
Publicado: (2021) -
RdRp or RT, That is the Question
por: Peyambari, Mahtab, et al.
Publicado: (2021) -
Snapshots of a Non-Canonical RdRP in Action
por: Ferrero, Diego S., et al.
Publicado: (2021) -
Aging correlates with lower threshold cycle values for RdRP/RdRP+S genes during molecular detection of SARS-CoV-2
por: Mikuła-Pietrasik, Justyna, et al.
Publicado: (2021) -
Derivation, Functionalization of (S)-Goniothalamin from Goniothalamus wightii and Their Derivative Targets SARS-CoV-2 M(Pro), S(Pro), and RdRp: A Pharmacological Perspective
por: Palani, Vino, et al.
Publicado: (2022)